A study published in the Annals of Internal Medicine, the result of a collaboration between CVS Caremark and scientists at the Brigham and Women's Hospital and the Harvard Medical School, compared ...
NEW YORK — Teva Pharmaceutical Industries Ltd. won final regulatory clearance Friday to market its generic version of cholesterol medication Zocor after a federal judge threw out a motion from a rival ...
Indianapolis-based WellPoint Inc. is in a tussle with the nation’s largest drug maker over the nation’s top-selling drug. New York-based Pfizer Inc., facing the loss of billions in sales of its ...
June 20, 2006 — -- This Friday, Merck's patent on the cholesterol - lowering drug Zocor will expire. There will now be a generic version of the drug for sale called Simvastatin. Are you taking ...
The erroneous findings emerged from data taken from a large managed-care-organization group of patients who had taken either atorvastatin or simvastatin. Within this cohort of approximately 80 000 ...
FDA review finds increased risk of muscle damage, kidney failure. June 9, 2011 — -- The U.S. Food and Drug Administration has recommended limiting high doses of a widely prescribed ...
Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL. Treatment of ...
Drugs known as statins are the first-choice treatment for high cholesterol but millions of people who can't or won't take those pills because of side effects may have another option. In a major study, ...
Generally, Medicare Part D and Part C plans that include drug coverage should cover simvastatin or other commonly prescribed cholesterol medications. Simvastatin (Zocor) is available as an oral tablet ...
What is simvastatin used for? Simvastatin is commonly used to lower bad cholesterol levels (LDL-C) and fats (triglycerides) in the blood. It also increases good cholesterol levels (HDL). Improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results